Latest Asx News

Argent Minerals has pushed silver mineralisation beyond the current Kempfield Lode 100 resource boundary with a broad 91.2m intercept from near surface, highlighting significant potential for resource growth and mine development optionality.

Charger Metals has extended spodumene mineralisation at its Medcalf deposit to 700 metres depth, prompting a pending resource upgrade beyond the maiden 8.2Mt @ 1.0% Li2O estimate.

Anson Resources and POSCO Holdings have sealed a binding deal for a $7.2 million lithium extraction demonstration plant at Green River, advancing the project from concept to operational validation.

Sunshine Metals has reported standout drilling results from its Liontown Gold Panel, including 22 metres at 20.25 grams per tonne gold, underpinning a resource update and revised mining study planned for mid-2026.

FirstWave Cloud Technology delivered a strong Q3 FY26 with a $1.40m net operating cash inflow and a major two-year licensing agreement with Mexico’s Banobras bank, marking a key milestone in its AI compliance pivot.

DGR Global has invested $3 million in Savannah Goldfields through a $1.5 million gold production royalty and a $1.5 million share placement, securing a foothold in North Queensland’s gold sector with potential for significant cash flow and exploration upside.

European Resources Limited has closed a renounceable rights issue raising $2.57 million before costs, issuing 171.4 million new shares and options to fuel exploration and metallurgical programs in Finland and Slovakia.

MRG Metals has verified substantial concentrations of valuable heavy minerals including monazite, rutile and zircon in alluvial deposits at its Adriano Rare Earth Project, with a total rare earth oxide content of 1.46%.

Hawk Resources has locked in $5.87 million through a placement and entitlement offer, backing its push into scandium exploration in Western Australia and copper drilling in the US.

Atlas Arteria reported a resilient 2025 with 9.3% EBITDA growth and steady toll revenue, while its Board unanimously urged investors to reject IFM’s unsolicited takeover offer, citing undervaluation and onerous conditions.

Neurizon Therapeutics has gained ethics approval to start a Phase 1 trial of its NUZ-001 oral liquid formulation, aiming to ease treatment for ALS patients with swallowing difficulties.

Regener8 Resources has formalised its acquisition of the Srebrenica North polymetallic project in Bosnia and Herzegovina, setting the stage for a maiden exploration program targeting high-grade silver and base metals in a prolific European mining district.